Mannkind (MNKD) Cash from Operations Growth (5y) (2015 - 2026)
Mannkind (MNKD) Cash from Operations Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,132.22 Bn | 67,131.94 Bn | - |
| 2 | Nanobiotix | 1,911.83 Bn | 1,911.77 Bn | - |
| 3 | Akari Therapeutics | 973.81 Bn | 973.81 Bn | - |
| 4 | BeOne Medicines | 471.45 Bn | 466.66 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.00 Bn | 114.75 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.99 Bn | 61.23 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.68 Bn | 62.68 Bn | - |
| 8 | Argenx Se | 55.86 Bn | 50.67 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.47 Bn | 34.46 Bn | 959.66 Mn |
| 10 | Mannkind | 1.25 Bn | 1.12 Bn | 82.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.87% |
| Dec 31, 2025 | -104.61% |
| Sep 30, 2025 | 30.30% |
| Jun 30, 2025 | 34.67% |
| Mar 31, 2025 | 10.68% |
| Dec 31, 2024 | 45.11% |
| Sep 30, 2024 | 16.86% |
| Jun 30, 2024 | 17.02% |
| Mar 31, 2024 | 20.85% |
| Dec 31, 2023 | -2.80% |
| Sep 30, 2023 | 21.27% |
| Jun 30, 2023 | 15.95% |
| Mar 31, 2023 | 15.48% |
| Dec 31, 2022 | 39.77% |
| Sep 30, 2022 | -3.82% |
| Jun 30, 2022 | -9.81% |
| Mar 31, 2022 | -32.89% |
| Dec 31, 2021 | 0.64% |
| Sep 30, 2021 | 8.03% |
| Jun 30, 2021 | -13.26% |